Oak Ridge National Laboratory

Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida

28-Oct-2020 2:15 PM EDT, by Oak Ridge National Laboratory

Newswise — A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

DemeTECH, a medical device manufacturer, is the state’s only National Institute for Occupational Safety and Health certified producer of the respirator masks which are needed to protect U.S. healthcare workers in the fight against COVID-19.

“We had no capability to make this material but wanted to be able to ramp up the production quickly,” said Luis Arguello, Jr., vice president of DemeTECH. “Through a connection at the U.S. Department of Defense’s Advanced Functional Fabrics of America, we were introduced to Oak Ridge National Laboratory and their recent success in making filter media material.”

National user facility resources

Scientific research that began at the DOE’s Carbon Fiber Technology Facility at ORNL provided melt blown filter material to DemeTECH so that they could develop their mask manufacturing processes. At the beginning of the COVID-19 pandemic in the U.S., ORNL researchers were presented with the challenge of how to produce filtration material on existing equipment typically used to mass produce precursor material for carbon fiber production.

CFTF Director Merlin Theodore turned to the precursor line’s melt blowing capability for the answer. The N95 mask is made of melt-blown polypropylene, or PP, a non-woven material that is permanently electrostatically charged with millions of microfibers layered on top of each other. The filter is capable of removing more than 95 percent of submicron particles found in viruses like COVID-19.

Melt blowing is the nonwoven process that makes microfibers into a fabric by scattering a polymer resin at a high air velocity. Randomly deposited fibers form a sheet of material applicable for filtration. Theodore and team consulted with Dr. Peter Tsai, the inventor of N95 electrostatically charged filter material, to integrate the process into the melt blowing line at the CFTF.

Tsai worked with the CFTF team to develop an inline charging technology for the melt blowing line and coordinated with staff at the DOE’s Manufacturing Demonstration Facility on material blending. Researchers across multiple disciplines at ORNL in materials science, characterization and systems and electrical engineering collaborated to adjust the speed and feed of the material to achieve the optimum production target.

“We’ve been successful in melt blowing PP continuously on the CFTF equipment,” Theodore said. “We successfully produced electrostatically charged filter media that met N95 target properties within 28 days.”

U.S. production

Before COVID-19, DemeTECH primarily manufactured wound closure medical devices such as surgical sutures and hernia mesh. The company began production of surgical and N95 masks in response to healthcare supply demand.

“We’re glad we connected with Oak Ridge National Lab and the Carbon Fiber Technology Facility at a time when they needed to transfer their research achievements to industry because we’re now able to mass produce and supply this critical material,” Arguello said.

Since pivoting the company’s capabilities to producing masks, DemeTECH has also opened two additional production facilities.

ORNL’s COVID manufacturing efforts are conducted in coordination with the U.S. Department of Health and Human Services and funded in part by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act. DOE’s Carbon Fiber Technology Facility COVID-19 efforts at ORNL are also supported by the Office Energy Efficiency and Renewable Energy’s Advanced Manufacturing Office

ORNL is managed by UT-Battelle for the U.S. Department of Energy's Office of Science, the single largest supporter of basic research in the physical sciences in the United States. DOE’s Office of Science is working to address some of the most pressing challenges of our time. For more information, please visit https://energy.gov/science.

 




Filters close

Showing results

110 of 4192
Released: 3-Dec-2020 9:00 AM EST
Sociologists Available to Discuss Vaccines and COVID-19
American Sociological Association (ASA)

As coronavirus cases rage throughout the United States—killing more than a quarter million in the U.S.—news of the effectiveness of vaccine candidates provides hope.

access_time Embargo lifts in 2 days
Embargo will expire: 8-Dec-2020 11:00 AM EST Released to reporters: 3-Dec-2020 8:30 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Dec-2020 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: The Medical Minute: Helping young athletes return to play safely after COVID-19
Released: 3-Dec-2020 8:20 AM EST
The Medical Minute: Helping young athletes return to play safely after COVID-19
Penn State Health

Young athletes in central Pennsylvania can’t wait to start basketball and wrestling season. But with the COVID-19 pandemic raging, parents wonder how their children can stay safe. And, if their child gets COVID-19, parents wonder when it’s safe for that child to get back to competitive sports.

Released: 2-Dec-2020 6:05 PM EST
How Caregivers of People with Dementia Can Navigate Holidays During the Pandemic
Rutgers University-New Brunswick

As COVID-19 cases increase across the nation, many caregivers are trying to navigate the holidays for relatives with dementia or Alzheimer’s disease. The Centers for Disease Control and Prevention suggests that people not travel to limit the potential spread of the coronavirus. Mary Catherine Lundquist, program director of Care2Caregivers, a peer counseling helpline (800-424-2494) for caregivers of people with dementia and Alzheimer’s disease operated by Rutgers Behavioral Health Care, discusses how families can stay connected with their loved ones.

Released: 2-Dec-2020 3:50 PM EST
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Fred Hutchinson Cancer Research Center

SEATTLE – Dec. 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.If you’re following the American Society of Hematology’s annual meeting (virtual, Dec. 5-8), see our media tip sheet highlighting Fred Hutch presentations and activities, including those by current ASH president Dr.

Newswise: “This is how we can help” – Couple shares their story as COVID-19 clinical trial participants
Released: 2-Dec-2020 2:35 PM EST
“This is how we can help” – Couple shares their story as COVID-19 clinical trial participants
University of Texas Health Science Center at Houston

“I don’t feel so great,” my husband, Brandon, said to me one Saturday afternoon – the last thing I wanted to hear after spending the last seven months tuned into COVID-19 media coverage. Knowing a few of his co-workers had recently tested positive for the virus, we didn’t wait to secure an appointment for a rapid test. When he called me an hour later to tell me he has tested positive, my heart sank.

Released: 2-Dec-2020 2:35 PM EST
IPC Statement On SARS-CoV-2 Vaccines And Psoriasis
International Psoriasis Council

The SARS-CoV-2 pandemic continues to have a considerable impact on the provision of appropriate care to people with psoriasis.

Newswise: 250245_web.jpg
Released: 2-Dec-2020 2:05 PM EST
Differences in immunity and blood vessels likely protect children from severe COVID-19
Murdoch Childrens Research Institute

Differences in the immune systems and better blood vessel health were among the factors protecting children from severe COVID-19, according to a new review.


Showing results

110 of 4192

close
0.98417